Lupin said that USFDA has completed an inspection of its Bioresearch Centre in Pune without any observation.
Nalco board has approved payment of the 2nd interim dividend of Rs 2.50/share on the paid-up equity share capital of Rs.918.32 cr for FY2022-23.
Swipe Up
Check More Details